GlassScriptPhysician profile
Loida Campos Herrera
NPI 1558361618
$1,411.59
in general payments reported to CMS, 2019-2025
12 companies · $504 in 2025
The $504 reported for 2025 was more than what 79% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $335 · 2020: $56.86 · 2021: $120 · 2022: $98.85 · 2023: $55.80 · 2024: $241 · 2025: $504.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $801.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $801.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $312.10 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $225.83 | 2020-2022 | |
| Lilly USA, LLC | $218.73 | 2024-2025 | Zepbound, Mounjaro |
| Boston Scientific Corporation | $128.89 | 2025 | General - Therapies, General - Brady |
| Novo Nordisk INC | $124.96 | 2025 | Ozempic |
| Mylan Specialty L.P. | $100.00 | 2019 | |
| Glaxosmithkline, LLC. | $89.60 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $68.23 | 2019-2025 | Airsupra |
| Merck Sharp & Dohme LLC | $56.66 | 2023-2024 | Vaxneuvance, Gardasil 9, Gardasil |
| Boehringer Ingelheim Pharmaceuticals, INC. | $48.70 | 2019-2020 | |
| Pbg Puerto Rico LLC | $20.00 | 2023 | |
| Sanofi-Aventis U.S. LLC | $17.89 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Loida Campos Herrera listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.